162 related articles for article (PubMed ID: 31596583)
1. Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.
Nguyen T; Gamage TF; Decker AM; Barrus D; Langston TL; Li JX; Thomas BF; Zhang Y
J Med Chem; 2019 Nov; 62(21):9806-9823. PubMed ID: 31596583
[TBL] [Abstract][Full Text] [Related]
2. Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.
Nguyen T; German N; Decker AM; Langston TL; Gamage TF; Farquhar CE; Li JX; Wiley JL; Thomas BF; Zhang Y
J Med Chem; 2017 Sep; 60(17):7410-7424. PubMed ID: 28792219
[TBL] [Abstract][Full Text] [Related]
3. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1).
German N; Decker AM; Gilmour BP; Gay EA; Wiley JL; Thomas BF; Zhang Y
J Med Chem; 2014 Sep; 57(18):7758-69. PubMed ID: 25162172
[TBL] [Abstract][Full Text] [Related]
4. Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.
Bertini S; Chicca A; Gado F; Arena C; Nieri D; Digiacomo M; Saccomanni G; Zhao P; Abood ME; Macchia M; Gertsch J; Manera C
Bioorg Med Chem; 2017 Dec; 25(24):6427-6434. PubMed ID: 29079014
[TBL] [Abstract][Full Text] [Related]
5. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
[TBL] [Abstract][Full Text] [Related]
6. Diarylureas Containing 5-Membered Heterocycles as CB
Nguyen T; Gamage TF; Decker AM; German N; Langston TL; Farquhar CE; Kenakin TP; Wiley JL; Thomas BF; Zhang Y
ACS Chem Neurosci; 2019 Jan; 10(1):518-527. PubMed ID: 30188693
[TBL] [Abstract][Full Text] [Related]
7. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
[TBL] [Abstract][Full Text] [Related]
8. PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor.
Meini S; Gado F; Stevenson LA; Digiacomo M; Saba A; Codini S; Macchia M; Pertwee RG; Bertini S; Manera C
Eur J Med Chem; 2020 Oct; 203():112606. PubMed ID: 32682199
[TBL] [Abstract][Full Text] [Related]
9. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
10. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
11. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum.
Wang X; Horswill JG; Whalley BJ; Stephens GJ
Mol Pharmacol; 2011 Apr; 79(4):758-67. PubMed ID: 21189269
[TBL] [Abstract][Full Text] [Related]
12. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
[TBL] [Abstract][Full Text] [Related]
13. Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior.
Nguyen T; Gamage TF; Finlay DB; Decker AM; Langston TL; Barrus D; Glass M; Li JX; Kenakin TP; Zhang Y
J Med Chem; 2022 Jan; 65(1):257-270. PubMed ID: 34929081
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
Dopart R; Lu D; Lichtman AH; Kendall DA
Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.
Qiao CJ; Ali HI; Ahn KH; Kolluru S; Kendall DA; Lu D
Eur J Med Chem; 2016 Oct; 121():517-529. PubMed ID: 27318976
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulators restore orthosteric agonist binding to mutated CB
Dopart R; Kendall DA
J Pharm Pharmacol; 2020 Jan; 72(1):84-91. PubMed ID: 31722122
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and evaluation of new PET ligands for peripheral cannabinoid receptor type 1 imaging.
Yamasaki T; Fujinaga M; Shimoda Y; Mori W; Zhang Y; Wakizaka H; Ogawa M; Zhang MR
Bioorg Med Chem Lett; 2017 Sep; 27(17):4114-4117. PubMed ID: 28757061
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure.
Garai S; Schaffer PC; Laprairie RB; Janero DR; Pertwee RG; Straiker A; Thakur GA
Bioorg Med Chem; 2021 Nov; 50():116421. PubMed ID: 34634617
[TBL] [Abstract][Full Text] [Related]
19. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model.
Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K
Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948
[TBL] [Abstract][Full Text] [Related]
20. 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.
Muccioli GG; Wouters J; Scriba GK; Poppitz W; Poupaert JH; Lambert DM
J Med Chem; 2005 Nov; 48(23):7486-90. PubMed ID: 16279809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
